• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项为期 4 年的随访研究中,EQ-5D 和 8 项帕金森病问卷(PDQ-8)的反应性。

Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.

机构信息

Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Block MD3, 16 Medical Drive, Singapore, 117597 Singapore.

出版信息

Qual Life Res. 2010 May;19(4):565-9. doi: 10.1007/s11136-010-9615-7. Epub 2010 Mar 4.

DOI:10.1007/s11136-010-9615-7
PMID:20204708
Abstract

OBJECTIVE

The purpose of this study was to evaluate the responsiveness of the EQ-5D and the Parkinson's Disease Questionnaire (PDQ-8) to deterioration in health-related quality of life (HRQoL) in patients with Parkinson's disease (PD).

METHODS

HRQoL and clinical data collected from 31 patients with PD (male: 74.2%, mean age: 61 years) who were surveyed with the EQ-5D and the PDQ-8 questionnaires in 2002 and 2006/2007 were analyzed. Responsiveness of the EQ-5D, PDQ-8, and Hoehn and Yahr (H&Y) staging were assessed according to Cohen's effect size (ES) and standardized response mean (SRM).

RESULTS

The mean (standard deviation) EQ-5D index and PDQ-8 summary index (PDQ-8SI) scores were 0.76 (0.23) and 17.7 (14.2) at baseline and 0.52 (0.33) and 35.1 (17.4) at year four. Based on both ES and SRM indices, the rank order of responsiveness of the studied measures, from high to low, was PDQ-8SI (ES = 1.22), EQ-5D index score (ES = 1.06), H&Y score (ES = 0.82), and the EQ-VAS score (ES = 0.24).

CONCLUSION

Both the EQ-5D and PDQ-8 are responsive to changes in health burden of the Parkinson's disease over a 4-year period.

摘要

目的

本研究旨在评估 EQ-5D 和帕金森病问卷(PDQ-8)对帕金森病(PD)患者健康相关生活质量(HRQoL)恶化的反应能力。

方法

对 2002 年和 2006/2007 年接受 EQ-5D 和 PDQ-8 问卷调查的 31 名 PD 患者(男性:74.2%,平均年龄:61 岁)的 HRQoL 和临床数据进行分析。根据 Cohen 的效应大小(ES)和标准化反应均值(SRM)评估 EQ-5D、PDQ-8 和 Hoehn 和 Yahr(H&Y)分期的反应能力。

结果

基线时,EQ-5D 指数和 PDQ-8 综合指数(PDQ-8SI)的平均值(标准差)分别为 0.76(0.23)和 17.7(14.2),四年后分别为 0.52(0.33)和 35.1(17.4)。根据 ES 和 SRM 指数,研究指标的反应能力从高到低的排序为 PDQ-8SI(ES=1.22)、EQ-5D 指数评分(ES=1.06)、H&Y 评分(ES=0.82)和 EQ-VAS 评分(ES=0.24)。

结论

EQ-5D 和 PDQ-8 在 4 年内均能敏感反映帕金森病患者的健康负担变化。

相似文献

1
Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.在一项为期 4 年的随访研究中,EQ-5D 和 8 项帕金森病问卷(PDQ-8)的反应性。
Qual Life Res. 2010 May;19(4):565-9. doi: 10.1007/s11136-010-9615-7. Epub 2010 Mar 4.
2
Convergent validation of EQ-5D-5L in patients with Parkinson's disease.帕金森病患者中EQ-5D-5L的收敛效度验证。
J Neurol Sci. 2015 Nov 15;358(1-2):53-7. doi: 10.1016/j.jns.2015.08.010. Epub 2015 Aug 7.
3
Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.美国帕金森病患者“OFF”发作对健康相关生活质量影响的真实世界评估。
BMC Neurol. 2021 Jan 30;21(1):46. doi: 10.1186/s12883-021-02074-2.
4
Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.EQ-5D对帕金森病患者而言是一种有效的生活质量评估工具吗?一项在新加坡开展的研究。
Ann Acad Med Singap. 2009 Jun;38(6):521-8.
5
Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.将 PDQ-39 评分映射到帕金森病患者的 EQ-5D 评分。
Qual Life Res. 2013 Jun;22(5):1065-72. doi: 10.1007/s11136-012-0231-6. Epub 2012 Jul 11.
6
The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.EQ-5D(一种通用的生活质量衡量工具)是评估帕金森病患者生活质量的有效手段。
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):67-73. doi: 10.1136/jnnp.69.1.67.
7
Parkinson's disease with early motor complications: predicting EQ-5D- 3L utilities from PDQ-39 data in the EARLYSTIM trial.帕金森病伴早期运动并发症:早期刺激试验中从 PDQ-39 数据预测 EQ-5D-3L 效用值。
Health Qual Life Outcomes. 2020 Mar 2;18(1):49. doi: 10.1186/s12955-020-01299-y.
8
Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the Endometriosis Health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D).测量子宫内膜异位症女性的健康相关生活质量:比较子宫内膜异位症健康量表-5(EHP-5)和欧洲五维健康量表(EQ-5D)的测量学特性。
Hum Reprod. 2017 Jun 1;32(6):1258-1269. doi: 10.1093/humrep/dex057.
9
Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.巴西帕金森病患者照顾者的负担和与健康相关的生活质量。
Parkinsonism Relat Disord. 2013 Nov;19(11):943-8. doi: 10.1016/j.parkreldis.2013.06.005. Epub 2013 Jul 4.
10
Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.帕金森病患者基于偏好的生活质量测量工具的结构效度和反应度评估:一项系统评价
Qual Life Res. 2017 Jan;26(1):1-23. doi: 10.1007/s11136-016-1428-x. Epub 2016 Oct 24.

引用本文的文献

1
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial.神经刺激治疗晚期帕金森病与 5 年生活质量:一项非随机对照试验。
JAMA Netw Open. 2024 Jan 2;7(1):e2352177. doi: 10.1001/jamanetworkopen.2023.52177.
2
Current Status of Acceptance of Disability and the Correlation With the Life Quality in Parkinson's Disease in Southwest China.中国西南地区帕金森病患者对残疾的接受现状及其与生活质量的相关性
Front Med (Lausanne). 2022 Jan 18;8:767215. doi: 10.3389/fmed.2021.767215. eCollection 2021.
3
Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

本文引用的文献

1
Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.EQ-5D对帕金森病患者而言是一种有效的生活质量评估工具吗?一项在新加坡开展的研究。
Ann Acad Med Singap. 2009 Jun;38(6):521-8.
2
Comparative responsiveness of Parkinson's disease scales to change over time.帕金森病量表随时间变化的比较反应性。
Mov Disord. 2009 Apr 30;24(6):813-8. doi: 10.1002/mds.22438.
3
Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's Disease Questionnaire (PDQ-8).
常用通用偏好量表在东亚和东南亚的测量特性:系统评价。
Pharmacoeconomics. 2020 Feb;38(2):159-170. doi: 10.1007/s40273-019-00854-w.
4
Palliative care for patients with Parkinson's disease: study protocol for a mixed methods study.帕金森病患者的姑息治疗:一项混合方法研究的研究方案。
BMC Palliat Care. 2017 Nov 25;16(1):61. doi: 10.1186/s12904-017-0248-2.
5
Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.帕金森病患者基于偏好的生活质量测量工具的结构效度和反应度评估:一项系统评价
Qual Life Res. 2017 Jan;26(1):1-23. doi: 10.1007/s11136-016-1428-x. Epub 2016 Oct 24.
6
Deep Brain Stimulation Can Preserve Working Status in Parkinson's Disease.深部脑刺激可维持帕金森病的工作状态。
Parkinsons Dis. 2015;2015:936865. doi: 10.1155/2015/936865. Epub 2015 Jul 30.
7
Can The EQ-5D Detect Meaningful Change? A Systematic Review.EQ-5D能否检测出有意义的变化?一项系统评价。
Pharmacoeconomics. 2015 Nov;33(11):1137-54. doi: 10.1007/s40273-015-0295-6.
8
Population norms for the EQ-5D index scores using Singapore preference weights.使用新加坡偏好权重的EQ-5D指数得分的人群规范。
Qual Life Res. 2015 Jun;24(6):1545-53. doi: 10.1007/s11136-014-0859-5. Epub 2014 Nov 14.
9
Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference?使用EQ-5D评估胶质瘤手术患者的生活质量:其反应性和最小临床重要差异是什么?
Qual Life Res. 2014 Jun;23(5):1427-34. doi: 10.1007/s11136-013-0593-4. Epub 2013 Dec 7.
10
Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.15-D 和 EQ-5D-5L 量表在西班牙帕金森病人群样本中的验证和比较。
Qual Life Res. 2014 May;23(4):1315-26. doi: 10.1007/s11136-013-0569-4. Epub 2013 Nov 22.
8项帕金森病问卷(PDQ-8)纵向效度及最小重要差异的测定
Mov Disord. 2009 Jan 30;24(2):183-7. doi: 10.1002/mds.22240.
4
Validation of PDQ-8 as an independent instrument in English and Chinese.验证PDQ-8作为英文和中文独立工具的有效性。
J Neurol Sci. 2007 Apr 15;255(1-2):77-80. doi: 10.1016/j.jns.2007.01.072. Epub 2007 Mar 2.
5
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.在一项前瞻性纵向研究中评估帕金森病患者与健康相关的生活质量。
Parkinsonism Relat Disord. 2007 Mar;13(2):108-14. doi: 10.1016/j.parkreldis.2006.07.009. Epub 2006 Oct 19.
6
Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.普拉克索与左旋多巴治疗早期帕金森病患者:对一般生活质量和疾病特异性生活质量的影响。
Value Health. 2006 Jan-Feb;9(1):28-38. doi: 10.1111/j.1524-4733.2006.00078.x.
7
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.左旋多巴与恩他卡朋联合使用对出现剂末现象波动的患者生活质量和日常生活活动的疗效。
Acta Neurol Scand. 2005 Jan;111(1):21-8. doi: 10.1111/j.1600-0404.2004.00363.x.
8
Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore.PDQ - 39和PDQ - 8在新加坡讲英语的帕金森病患者中的效度和信度
Parkinsonism Relat Disord. 2004 Dec;10(8):493-9. doi: 10.1016/j.parkreldis.2004.05.007.
9
Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial.普拉克索与左旋多巴作为帕金森病初始治疗的比较:一项随机临床经济学试验
Med Decis Making. 2004 Sep-Oct;24(5):472-85. doi: 10.1177/0272989X04268960.
10
Health related quality of life in Parkinson's disease: a prospective longitudinal study.帕金森病患者与健康相关的生活质量:一项前瞻性纵向研究。
J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):584-9. doi: 10.1136/jnnp.69.5.584.